Related Experiment Video
Updated: Apr 1, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.5K
[Primary aldosteronism: new insights into familial forms].
Anton H van den Meiracker1, Annelieke A A van der Linde, Hedi L Claahsen van der Grinten
1Erasmus Medisch Centrum, afd. Inwendige Geneeskunde, Rotterdam.
Nederlands Tijdschrift Voor Geneeskunde
|October 1, 2015
Summary
Primary aldosteronism, a condition of excess aldosterone, stems from adrenal issues and causes hypertension. Genetic mutations in KCNJ5 and other genes are key factors, especially in younger patients.
Area of Science:
- Endocrinology
- Genetics
- Nephrology
Background:
- Primary aldosteronism (PA) involves autonomous aldosterone overproduction, often causing severe hypertension and hypokalemia.
- PA presents heterogeneously, arising from adrenal adenoma, hyperplasia, or rare familial genetic causes.
Purpose of the Study:
- To elucidate the genetic underpinnings of primary aldosteronism.
- To highlight the role of KCNJ5 mutations in PA pathogenesis and clinical presentation.
Main Methods:
- Review of genetic mutations associated with primary aldosteronism.
- Analysis of KCNJ5 gene mutations (germline and somatic) in aldosterone-producing adenomas.
- Examination of familial aldosteronism types 1 and 3.
Main Results:
- Mutations in KCNJ5 are implicated in approximately 40% of aldosterone-producing adrenal adenomas.
- Familial aldosteronism type 3 is linked to KCNJ5 mutations, with variable clinical severity.
- Mutations in KCNJ5 and other genes consistently increase aldosterone synthase activity, leading to PA.
Conclusions:
- Genetic factors, particularly KCNJ5 mutations, play a significant role in primary aldosteronism.
- Excluding familial forms of PA is crucial in patients under 20 before considering adrenalectomy.
Related Concept Videos
01:27Adrenal Gland Disorders
3.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.9K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.7K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K
01:33Hormonal Regulation
37.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:29Hypertension II: Pathophysiology
1.5K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.8K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K